Lippincott ^® NursingCenter ^®

Departments

• Free

  3 Questions on...How Economic Downturns Affect Cancer Outcomes: With MAHIBEN MARUTHAPPU, MD, Senior Fellow to the CEO of NHS England

  Sarah DiGiulio

• Free

  Can Patients With Metastatic RCC Safely Defer Systemic Therapy?

  Michael R. Harrison MD

• Free

  Children With Neuroblastoma Improve With Double Stem Cell Transplant

  Romi Herron-Cologna

• Free

  FDA Approves Netspot to Detect Rare Neuroendocrine Tumors
• Free

  FDA Grants Orphan Drug Designation for Napabucasin in Treating Gastric/GEJ Cancer
• Free

  Historical Perspectives of a Veteran Physician

  Joseph V. Simone MD

• Free

  Immunotherapy After Chemo May Stop Ovarian Cancer From Coming Back
• Free

  More Than Half of CML Patients in Remission After Stopping Nilotinib

  Mark L. Fuerst

• Free

  Neanderthals & Viral DNA

  George W. Sledge MD

• Free

  Patients' Genetic Inheritance

  Wendy Harpham MD, FACP

• Free

  Persistent HPV Infection Raises Risk of Anal & Genital Cancers
• Free

  Shop Talk
• Free

  Testicular Cancer Survivors May Have Hearing Loss After Cisplatin Therapy
• Free

  The Rapidly Changing Landscape of Molecular Diagnostics

  Philip S. Bernard MD

• Free

  The Right Timing Leads to a New Weapon in Brain Cancer Research
• Free

  Too Fat or Too Thin Might Be Bad for Lung Surgery

  Ed Susman

• Free

  UpToDate®
• Free

  Welcome to WKOncology.com

  Lynn Nace

• Buy

  Ibrutinib Granted Breakthrough Therapy Designation for cGVHD Treatment
• Buy

  Solutions to Meet Global Challenge of Rising Cancer Costs

  Peggy Eastman

• Buy

  New Firstline Treatment for Older Patients With Secondary AML

  Mark L. Fuerst